Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

A Novel Intervention for Patients With Cancer

Study ID: NCT05643027
Start Date: 2023-03-01
End Date: 2026-06-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Acceptance and Commitment Therapy

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Study ID: NCT04903873
Start Date: 2021-05-31
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

U101

Sponsor

Eutilex

Source: clinicaltrials.gov

Share:
Add to list

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Study ID: NCT06060873
Start Date: 2023-06-08
End Date: 2028-12-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

418

Intervention / Treatment

Non-Interventional Study

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment

Study ID: NCT06532773
Start Date: 2025-07
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Nite2Day+

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

Study ID: NCT05973773
Start Date: 2023-06-30
End Date: 2026-08-24
Study Type

Interventional

Study Phase

Phase3

No. of Participants

272

Intervention / Treatment

TAS6417

Sponsor

Taiho Oncology, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

Study ID: NCT04717427
Start Date: 2021-09-08
End Date: 2025-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

250

Intervention / Treatment
Sponsor

University of Illinois at Chicago

Source: clinicaltrials.gov

Share:
Add to list

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Study ID: NCT06311227
Start Date: 2025-05-15
End Date: 2027-05-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Study ID: NCT04560673
Start Date: 2020-07-10
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

380

Intervention / Treatment

Duloxetine

Neurofeedback

Quality-of-Life Assessment

Administration questionnaire

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Study ID: NCT04450173
Start Date: 2021-02-24
End Date: 2026-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Ibrutinib

Obinutuzumab

Venetoclax

Sponsor

Joseph Tuscano

Source: clinicaltrials.gov

Share:
Add to list

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Study ID: NCT06028373
Start Date: 2023-12-08
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

ATG-031

Sponsor

Antengene Biologics Limited

Source: clinicaltrials.gov

Share:
Add to list